Oral or injectable semaglutide: what’s the difference?

Oral or injectable semaglutide: what’s the difference?

Short answer: Injectable semaglutide (Wegovy) results in greater weight loss on average than the oral tablet (Rybelsus), but the tablet is a fully-fledged alternative for those who wish to avoid injections. A doctor will determine which form is right for you.

Semaglutide is available in two forms: as a weekly injection (Wegovy) and as a daily tablet (Rybelsus). Both suppress appetite via the same mechanism, but they differ significantly in how the body absorbs them, how effective they are for weight loss, and what the practical pros and cons are. In this blog, you can read what semaglutide (Ozempic) is, how the two forms compare, and how Goodweigh will help you make the right choice.

What is the difference between oral and injectable semaglutide?

The main technical difference lies in how the drug is absorbed by the body. Subcutaneous semaglutide has a bioavailability of approximately 89 per cent, meaning that almost the entire dose enters the bloodstream. With the tablet, the situation is very different: bioavailability is only 1 to 2 per cent, and in a small group of patients it is virtually zero. According to the Pharmacotherapeutic Compass, absorption is so unpredictable that oral GLP-1 agonists are not preferred over subcutaneous formulations, particularly in patients at high cardiovascular risk.

To compensate for this low absorption, Rybelsus (oral semaglutide) contains the excipient SNAC, which facilitates absorption through the stomach lining. However, this only works under strict conditions: the tablet must be taken on an empty stomach with a maximum of 120 ml of water, and you must then wait at least 30 minutes before eating, drinking or taking any other medication. Such restrictions do not apply to the injectable form.

Rybelsus is authorised for the treatment of type 2 diabetes, not primarily for weight loss. The high-dose injectable semaglutide (Wegovy 2.4 mg/week) is the only one with official authorisation for obesity and overweight in adults. This distinction is also relevant for reimbursement: the indication for which you are using semaglutide determines whether reimbursement applies.

Which form is more effective for weight loss?

Injectable semaglutide results in greater weight loss on average, although the difference is smaller than you might expect. A large phase 3 study shows that oral semaglutide 25 mg led to an average weight reduction of 13.6% over 68 weeks in overweight people. That is an impressive result. However, a meta-analysis of 12 randomised studies (n=6,253) shows that injectable semaglutide results in an average of 2.19 kg more weight loss than the oral form. How much weight you can lose with semaglutide also depends heavily on your starting weight, lifestyle and how consistently you follow the treatment.

Below is an overview of the key differences.

Oral vs injectable semaglutide: overview

Based on the current state of research, the injectable form is clearly the preferred option if maximum effectiveness is the goal. Nevertheless, oral semaglutide performs significantly better than placebo and better than subcutaneous liraglutide: the PIONEER 4 study shows that oral semaglutide 14 mg led to 4.4 kg of weight loss versus 3.1 kg with subcutaneous liraglutide.

What are the advantages of the tablet?

The main advantage is practical: no needles, no fear of injections, no need to store pens in the fridge. For people who absolutely do not want injections, Rybelsus (oral semaglutide) is a serious option. The tablet also fits more easily into a morning routine without the need for medical procedures.

Furthermore, some people are already achieving very good results with the tablet. The higher doses (25 mg) that have recently been studied show that the gap compared to the injection narrows as the dose increases. For people with mild obesity or who are overweight, the tablet may be sufficient to reach their weight target.

What are the advantages of the injection?

Wegovy (high-dose semaglutide injection) offers a much more predictable effect. The high bioavailability of ~89% means that the active dose is consistently absorbed by the body, regardless of when you eat or what other medication you are taking. This also makes dose optimisation easier for the treating doctor.

Furthermore, Wegovy is the only semaglutide formulation with proven cardiovascular risk reduction in obesity, as demonstrated in the SELECT study. Real-world research shows that adherence after 18 months is 84% for injectable semaglutide, compared with just 46% for the oral version. This significant difference in adherence plays an important role in the overall outcome in the long term.

A weekly injection also requires less daily discipline than a tablet, where timing and taking the medication on an empty stomach are crucial for its effectiveness. Those who keep the barrier to injection low by linking it to a fixed day of the week generally find the practical burden to be minimal.

Are the side effects different between oral and injectable semaglutide?

The side effects largely overlap. Both forms cause gastrointestinal symptoms such as nausea, diarrhoea, vomiting and constipation, particularly during the build-up phase. Serious but rare side effects such as acute pancreatitis and kidney failure apply to both forms. For a complete picture, read more about the side effects of semaglutide.

However, there are two relevant differences. The tablet is more likely to cause local stomach discomfort because the active ingredient is absorbed in the stomach rather than subcutaneously, and higher doses of Rybelsus are associated with more dysgeusia (taste disturbances). The injection causes a reaction at the injection site in some users, such as redness or slight swelling. A 12-month study shows that injectable semaglutide results in greater weight loss, particularly in men, which indirectly also affects the balance of side effects at higher doses.

What does Goodweigh offer?

Goodweigh provides medical support for your treatment with semaglutide via an online consultation with one of our doctors. Based on your medical history, preferences and weight goal, the doctor will advise which form is most suitable. This ensures that a personalised assessment is always carried out to determine whether the tablet or the injection is the best choice for you.

Following the initial consultation, Goodweigh arranges the prescriptions and the medication is discreetly delivered to your home. Throughout the process, you remain in contact with your doctor: guidance is also provided on dose escalation and any side effects, so you are never left to manage this alone. A 12-month study shows that support and consistent treatment are key to the ultimate weight loss, regardless of which form of semaglutide you use.

The right form of semaglutide: deciding together with Goodweigh

Both oral and injectable semaglutide have been proven effective for weight loss. On average, the injectable form delivers better results and higher long-term adherence. The tablet is a fully-fledged alternative for those who do not wish to have injections, provided the strict dosage instructions are followed. You can decide which form is best for you in consultation with a doctor. Book an initial consultation via Goodweigh and start your journey in a medically responsible way.